Table of Content

1 Market Overview of Immune-mediated Necrotizing Myopathy Treatment
1.1 Immune-mediated Necrotizing Myopathy Treatment Market Overview
1.1.1 Immune-mediated Necrotizing Myopathy Treatment Product Scope
1.1.2 Immune-mediated Necrotizing Myopathy Treatment Market Status and Outlook
1.2 Global Immune-mediated Necrotizing Myopathy Treatment Market Size Overview by Region 2024 VS 2022 VS 2034
1.3 Global Immune-mediated Necrotizing Myopathy Treatment Market Size by Region (2024-2034)
1.4 Global Immune-mediated Necrotizing Myopathy Treatment Historic Market Size by Region (2024-2024)
1.5 Global Immune-mediated Necrotizing Myopathy Treatment Market Size Forecast by Region (2024-2034)
1.6 Key Regions, Immune-mediated Necrotizing Myopathy Treatment Market Size (2024-2034)
1.6.1 North America Immune-mediated Necrotizing Myopathy Treatment Market Size (2024-2034)
1.6.2 Europe Immune-mediated Necrotizing Myopathy Treatment Market Size (2024-2034)
1.6.3 Asia-Pacific Immune-mediated Necrotizing Myopathy Treatment Market Size (2024-2034)
1.6.4 Latin America Immune-mediated Necrotizing Myopathy Treatment Market Size (2024-2034)
1.6.5 Middle East & Africa Immune-mediated Necrotizing Myopathy Treatment Market Size (2024-2034)
2 Immune-mediated Necrotizing Myopathy Treatment Market by Type
2.1 Introduction
2.1.1 Steroids
2.1.2 Immunosuppressant
2.1.3 Others
2.2 Global Immune-mediated Necrotizing Myopathy Treatment Market Size by Type: 2024 VS 2022 VS 2034
2.2.1 Global Immune-mediated Necrotizing Myopathy Treatment Historic Market Size by Type (2024-2024)
2.2.2 Global Immune-mediated Necrotizing Myopathy Treatment Forecasted Market Size by Type (2024-2034)
2.3 Key Regions Market Size by Type
2.3.1 North America Immune-mediated Necrotizing Myopathy Treatment Revenue Breakdown by Type (2024-2034)
2.3.2 Europe Immune-mediated Necrotizing Myopathy Treatment Revenue Breakdown by Type (2024-2034)
2.3.3 Asia-Pacific Immune-mediated Necrotizing Myopathy Treatment Revenue Breakdown by Type (2024-2034)
2.3.4 Latin America Immune-mediated Necrotizing Myopathy Treatment Revenue Breakdown by Type (2024-2034)
2.3.5 Middle East and Africa Immune-mediated Necrotizing Myopathy Treatment Revenue Breakdown by Type (2024-2034)
3 Immune-mediated Necrotizing Myopathy Treatment Market Overview by Application
3.1 Introduction
3.1.1 Hospital
3.1.2 Clinic
3.1.3 Others
3.2 Global Immune-mediated Necrotizing Myopathy Treatment Market Size by Application: 2024 VS 2022 VS 2034
3.2.1 Global Immune-mediated Necrotizing Myopathy Treatment Historic Market Size by Application (2024-2024)
3.2.2 Global Immune-mediated Necrotizing Myopathy Treatment Forecasted Market Size by Application (2024-2034)
3.3 Key Regions Market Size by Application
3.3.1 North America Immune-mediated Necrotizing Myopathy Treatment Revenue Breakdown by Application (2024-2034)
3.3.2 Europe Immune-mediated Necrotizing Myopathy Treatment Revenue Breakdown by Application (2024-2034)
3.3.3 Asia-Pacific Immune-mediated Necrotizing Myopathy Treatment Revenue Breakdown by Application (2024-2034)
3.3.4 Latin America Immune-mediated Necrotizing Myopathy Treatment Revenue Breakdown by Application (2024-2034)
3.3.5 Middle East and Africa Immune-mediated Necrotizing Myopathy Treatment Revenue Breakdown by Application (2024-2034)
4 Immune-mediated Necrotizing Myopathy Treatment Competition Analysis by Players
4.1 Global Immune-mediated Necrotizing Myopathy Treatment Market Size by Players (2024-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Immune-mediated Necrotizing Myopathy Treatment as of 2022)
4.3 Date of Key Players Enter into Immune-mediated Necrotizing Myopathy Treatment Market
4.4 Global Top Players Immune-mediated Necrotizing Myopathy Treatment Headquarters and Area Served
4.5 Key Players Immune-mediated Necrotizing Myopathy Treatment Product Solution and Service
4.6 Competitive Status
4.6.1 Immune-mediated Necrotizing Myopathy Treatment Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 GlaxoSmithKline plc
5.1.1 GlaxoSmithKline plc Profile
5.1.2 GlaxoSmithKline plc Main Business
5.1.3 GlaxoSmithKline plc Immune-mediated Necrotizing Myopathy Treatment Products, Services and Solutions
5.1.4 GlaxoSmithKline plc Immune-mediated Necrotizing Myopathy Treatment Revenue (US$ Million) & (2024-2024)
5.1.5 GlaxoSmithKline plc Recent Developments
5.2 Dr. Reddy's Laboratories
5.2.1 Dr. Reddy's Laboratories Profile
5.2.2 Dr. Reddy's Laboratories Main Business
5.2.3 Dr. Reddy's Laboratories Immune-mediated Necrotizing Myopathy Treatment Products, Services and Solutions
5.2.4 Dr. Reddy's Laboratories Immune-mediated Necrotizing Myopathy Treatment Revenue (US$ Million) & (2024-2024)
5.2.5 Dr. Reddy's Laboratories Recent Developments
5.3 Genentech USA, Inc. (F. Hoffmann-La Roche Ltd.)
5.3.1 Genentech USA, Inc. (F. Hoffmann-La Roche Ltd.) Profile
5.3.2 Genentech USA, Inc. (F. Hoffmann-La Roche Ltd.) Main Business
5.3.3 Genentech USA, Inc. (F. Hoffmann-La Roche Ltd.) Immune-mediated Necrotizing Myopathy Treatment Products, Services and Solutions
5.3.4 Genentech USA, Inc. (F. Hoffmann-La Roche Ltd.) Immune-mediated Necrotizing Myopathy Treatment Revenue (US$ Million) & (2024-2024)
5.3.5 Hetero Drugs Limited Recent Developments
5.4 Hetero Drugs Limited
5.4.1 Hetero Drugs Limited Profile
5.4.2 Hetero Drugs Limited Main Business
5.4.3 Hetero Drugs Limited Immune-mediated Necrotizing Myopathy Treatment Products, Services and Solutions
5.4.4 Hetero Drugs Limited Immune-mediated Necrotizing Myopathy Treatment Revenue (US$ Million) & (2024-2024)
5.4.5 Hetero Drugs Limited Recent Developments
5.5 AbbVie Inc.
5.5.1 AbbVie Inc. Profile
5.5.2 AbbVie Inc. Main Business
5.5.3 AbbVie Inc. Immune-mediated Necrotizing Myopathy Treatment Products, Services and Solutions
5.5.4 AbbVie Inc. Immune-mediated Necrotizing Myopathy Treatment Revenue (US$ Million) & (2024-2024)
5.5.5 AbbVie Inc. Recent Developments
5.6 Teva Pharmaceutical Industries
5.6.1 Teva Pharmaceutical Industries Profile
5.6.2 Teva Pharmaceutical Industries Main Business
5.6.3 Teva Pharmaceutical Industries Immune-mediated Necrotizing Myopathy Treatment Products, Services and Solutions
5.6.4 Teva Pharmaceutical Industries Immune-mediated Necrotizing Myopathy Treatment Revenue (US$ Million) & (2024-2024)
5.6.5 Teva Pharmaceutical Industries Recent Developments
5.7 Novartis AG
5.7.1 Novartis AG Profile
5.7.2 Novartis AG Main Business
5.7.3 Novartis AG Immune-mediated Necrotizing Myopathy Treatment Products, Services and Solutions
5.7.4 Novartis AG Immune-mediated Necrotizing Myopathy Treatment Revenue (US$ Million) & (2024-2024)
5.7.5 Novartis AG Recent Developments
6 North America
6.1 North America Immune-mediated Necrotizing Myopathy Treatment Market Size by Country (2024-2034)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Immune-mediated Necrotizing Myopathy Treatment Market Size by Country (2024-2034)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Immune-mediated Necrotizing Myopathy Treatment Market Size by Region (2024-2034)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Immune-mediated Necrotizing Myopathy Treatment Market Size by Country (2024-2034)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Immune-mediated Necrotizing Myopathy Treatment Market Size by Country (2024-2034)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Immune-mediated Necrotizing Myopathy Treatment Market Dynamics
11.1 Immune-mediated Necrotizing Myopathy Treatment Industry Trends
11.2 Immune-mediated Necrotizing Myopathy Treatment Market Drivers
11.3 Immune-mediated Necrotizing Myopathy Treatment Market Challenges
11.4 Immune-mediated Necrotizing Myopathy Treatment Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Immune-mediated Necrotizing Myopathy Treatment Market Size (US$ Million) Comparison by Region 2024 VS 2022 VS 2034
Table 2. Global Immune-mediated Necrotizing Myopathy Treatment Market Size by Region (2024-2024) & (US$ Million)
Table 3. Global Immune-mediated Necrotizing Myopathy Treatment Market Size Share by Region (2024-2024)
Table 4. Global Immune-mediated Necrotizing Myopathy Treatment Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 5. Global Immune-mediated Necrotizing Myopathy Treatment Forecasted Market Size Share by Region (2024-2034)
Table 6. Global Immune-mediated Necrotizing Myopathy Treatment Market Size (US$ Million) by Type: 2024 VS 2022 VS 2034
Table 7. Global Immune-mediated Necrotizing Myopathy Treatment Market Size by Type (2024-2024) & (US$ Million)
Table 8. Global Immune-mediated Necrotizing Myopathy Treatment Revenue Market Share by Type (2024-2024)
Table 9. Global Immune-mediated Necrotizing Myopathy Treatment Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 10. Global Immune-mediated Necrotizing Myopathy Treatment Revenue Market Share by Type (2024-2034)
Table 11. North America Immune-mediated Necrotizing Myopathy Treatment Revenue by Type (2024-2024) & (US$ Million)
Table 12. North America Immune-mediated Necrotizing Myopathy Treatment Revenue by Type (2024-2034) & (US$ Million)
Table 13. Europe Immune-mediated Necrotizing Myopathy Treatment Revenue by Type (2024-2024) & (US$ Million)
Table 14. Europe Immune-mediated Necrotizing Myopathy Treatment Revenue by Type (2024-2034) & (US$ Million)
Table 15. Asia-Pacific Immune-mediated Necrotizing Myopathy Treatment Revenue by Type (2024-2024) & (US$ Million)
Table 16. Asia-Pacific Immune-mediated Necrotizing Myopathy Treatment Revenue by Type (2024-2034) & (US$ Million)
Table 17. Latin America Immune-mediated Necrotizing Myopathy Treatment Revenue by Type (2024-2024) & (US$ Million)
Table 18. Latin America Immune-mediated Necrotizing Myopathy Treatment Revenue by Type (2024-2034) & (US$ Million)
Table 19. Middle East and Africa Immune-mediated Necrotizing Myopathy Treatment Revenue by Type (2024-2024) & (US$ Million)
Table 20. Middle East and Africa Immune-mediated Necrotizing Myopathy Treatment Revenue by Type (2024-2034) & (US$ Million)
Table 21. Global Immune-mediated Necrotizing Myopathy Treatment Market Size (US$ Million) by Application: 2024 VS 2022 VS 2034
Table 22. Global Immune-mediated Necrotizing Myopathy Treatment Market Size by Application (2024-2024) & (US$ Million)
Table 23. Global Immune-mediated Necrotizing Myopathy Treatment Revenue Market Share by Application (2024-2024)
Table 24. Global Immune-mediated Necrotizing Myopathy Treatment Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 25. Global Immune-mediated Necrotizing Myopathy Treatment Revenue Market Share by Application (2024-2034)
Table 26. North America Immune-mediated Necrotizing Myopathy Treatment Revenue by Application (2024-2024) & (US$ Million)
Table 27. North America Immune-mediated Necrotizing Myopathy Treatment Revenue by Application (2024-2034) & (US$ Million)
Table 28. Europe Immune-mediated Necrotizing Myopathy Treatment Revenue by Application (2024-2024) & (US$ Million)
Table 29. Europe Immune-mediated Necrotizing Myopathy Treatment Revenue by Application (2024-2034) & (US$ Million)
Table 30. Asia-Pacific Immune-mediated Necrotizing Myopathy Treatment Revenue by Application (2024-2024) & (US$ Million)
Table 31. Asia-Pacific Immune-mediated Necrotizing Myopathy Treatment Revenue by Application (2024-2034) & (US$ Million)
Table 32. Latin America Immune-mediated Necrotizing Myopathy Treatment Revenue by Application (2024-2024) & (US$ Million)
Table 33. Latin America Immune-mediated Necrotizing Myopathy Treatment Revenue by Application (2024-2034) & (US$ Million)
Table 34. Middle East and Africa Immune-mediated Necrotizing Myopathy Treatment Revenue by Application (2024-2024) & (US$ Million)
Table 35. Middle East and Africa Immune-mediated Necrotizing Myopathy Treatment Revenue by Application (2024-2034) & (US$ Million)
Table 36. Global Immune-mediated Necrotizing Myopathy Treatment Revenue (US$ Million) by Players (2024-2024)
Table 37. Global Immune-mediated Necrotizing Myopathy Treatment Revenue Market Share by Players (2024-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Immune-mediated Necrotizing Myopathy Treatment as of 2022)
Table 39. Date of Key Players Enter into Immune-mediated Necrotizing Myopathy Treatment Market
Table 40. Global Immune-mediated Necrotizing Myopathy Treatment Key Players Headquarters and Area Served
Table 41. Immune-mediated Necrotizing Myopathy Treatment Product Solution and Service
Table 42. Global Immune-mediated Necrotizing Myopathy Treatment Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. GlaxoSmithKline plc Basic Information List
Table 45. GlaxoSmithKline plc Description and Business Overview
Table 46. GlaxoSmithKline plc Immune-mediated Necrotizing Myopathy Treatment Products, Services and Solutions
Table 47. Revenue (US$ Million) in Immune-mediated Necrotizing Myopathy Treatment Business of GlaxoSmithKline plc (2024-2024)
Table 48. GlaxoSmithKline plc Recent Developments
Table 49. Dr. Reddy's Laboratories Basic Information List
Table 50. Dr. Reddy's Laboratories Description and Business Overview
Table 51. Dr. Reddy's Laboratories Immune-mediated Necrotizing Myopathy Treatment Products, Services and Solutions
Table 52. Revenue (US$ Million) in Immune-mediated Necrotizing Myopathy Treatment Business of Dr. Reddy's Laboratories (2024-2024)
Table 53. Dr. Reddy's Laboratories Recent Developments
Table 54. Genentech USA, Inc. (F. Hoffmann-La Roche Ltd.) Basic Information List
Table 55. Genentech USA, Inc. (F. Hoffmann-La Roche Ltd.) Description and Business Overview
Table 56. Genentech USA, Inc. (F. Hoffmann-La Roche Ltd.) Immune-mediated Necrotizing Myopathy Treatment Products, Services and Solutions
Table 57. Revenue (US$ Million) in Immune-mediated Necrotizing Myopathy Treatment Business of Genentech USA, Inc. (F. Hoffmann-La Roche Ltd.) (2024-2024)
Table 58. Genentech USA, Inc. (F. Hoffmann-La Roche Ltd.) Recent Developments
Table 59. Hetero Drugs Limited Basic Information List
Table 60. Hetero Drugs Limited Description and Business Overview
Table 61. Hetero Drugs Limited Immune-mediated Necrotizing Myopathy Treatment Products, Services and Solutions
Table 62. Revenue (US$ Million) in Immune-mediated Necrotizing Myopathy Treatment Business of Hetero Drugs Limited (2024-2024)
Table 63. Hetero Drugs Limited Recent Developments
Table 64. AbbVie Inc. Basic Information List
Table 65. AbbVie Inc. Description and Business Overview
Table 66. AbbVie Inc. Immune-mediated Necrotizing Myopathy Treatment Products, Services and Solutions
Table 67. Revenue (US$ Million) in Immune-mediated Necrotizing Myopathy Treatment Business of AbbVie Inc. (2024-2024)
Table 68. AbbVie Inc. Recent Developments
Table 69. Teva Pharmaceutical Industries Basic Information List
Table 70. Teva Pharmaceutical Industries Description and Business Overview
Table 71. Teva Pharmaceutical Industries Immune-mediated Necrotizing Myopathy Treatment Products, Services and Solutions
Table 72. Revenue (US$ Million) in Immune-mediated Necrotizing Myopathy Treatment Business of Teva Pharmaceutical Industries (2024-2024)
Table 73. Teva Pharmaceutical Industries Recent Developments
Table 74. Novartis AG Basic Information List
Table 75. Novartis AG Description and Business Overview
Table 76. Novartis AG Immune-mediated Necrotizing Myopathy Treatment Products, Services and Solutions
Table 77. Revenue (US$ Million) in Immune-mediated Necrotizing Myopathy Treatment Business of Novartis AG (2024-2024)
Table 78. Novartis AG Recent Developments
Table 79. North America Immune-mediated Necrotizing Myopathy Treatment Market Size by Country (2024-2024) & (US$ Million)
Table 80. North America Immune-mediated Necrotizing Myopathy Treatment Market Size by Country (2024-2034) & (US$ Million)
Table 81. Europe Immune-mediated Necrotizing Myopathy Treatment Market Size by Country (2024-2024) & (US$ Million)
Table 82. Europe Immune-mediated Necrotizing Myopathy Treatment Market Size by Country (2024-2034) & (US$ Million)
Table 83. Asia-Pacific Immune-mediated Necrotizing Myopathy Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 84. Asia-Pacific Immune-mediated Necrotizing Myopathy Treatment Market Size by Region (2024-2024) & (US$ Million)
Table 85. Asia-Pacific Immune-mediated Necrotizing Myopathy Treatment Market Size by Region (2024-2034) & (US$ Million)
Table 86. Asia-Pacific Immune-mediated Necrotizing Myopathy Treatment Market Share by Region (2024-2024)
Table 87. Asia-Pacific Immune-mediated Necrotizing Myopathy Treatment Market Share by Region (2024-2034)
Table 88. Latin America Immune-mediated Necrotizing Myopathy Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 89. Latin America Immune-mediated Necrotizing Myopathy Treatment Market Size by Country (2024-2024) & (US$ Million)
Table 90. Latin America Immune-mediated Necrotizing Myopathy Treatment Market Size by Country (2024-2034) & (US$ Million)
Table 91. Middle East & Africa Immune-mediated Necrotizing Myopathy Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 92. Middle East & Africa Immune-mediated Necrotizing Myopathy Treatment Market Size by Country (2024-2024) & (US$ Million)
Table 93. Middle East & Africa Immune-mediated Necrotizing Myopathy Treatment Market Size by Country (2024-2034) & (US$ Million)
Table 94. Immune-mediated Necrotizing Myopathy Treatment Market Trends
Table 95. Immune-mediated Necrotizing Myopathy Treatment Market Drivers
Table 96. Immune-mediated Necrotizing Myopathy Treatment Market Challenges
Table 97. Immune-mediated Necrotizing Myopathy Treatment Market Restraints
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Immune-mediated Necrotizing Myopathy Treatment Market Size Year-over-Year 2024-2034 & (US$ Million)
Figure 2. Global Immune-mediated Necrotizing Myopathy Treatment Market Size (US$ Million), 2024 VS 2022 VS 2034
Figure 3. Global Immune-mediated Necrotizing Myopathy Treatment Market Share by Regions: 2022 VS 2034
Figure 4. Global Immune-mediated Necrotizing Myopathy Treatment Forecasted Market Size Share by Region (2024-2034)
Figure 5. North America Immune-mediated Necrotizing Myopathy Treatment Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 6. Europe Immune-mediated Necrotizing Myopathy Treatment Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 7. Asia-Pacific Immune-mediated Necrotizing Myopathy Treatment Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 8. Latin America Immune-mediated Necrotizing Myopathy Treatment Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 9. Middle East & Africa Immune-mediated Necrotizing Myopathy Treatment Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 10. Product Picture of Steroids
Figure 11. Global Steroids Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 12. Product Picture of Immunosuppressant
Figure 13. Global Immunosuppressant Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 14. Product Picture of Others
Figure 15. Global Others Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 16. Global Immune-mediated Necrotizing Myopathy Treatment Market Size Share by Type: 2022 & 2034
Figure 17. North America Immune-mediated Necrotizing Myopathy Treatment Revenue Market Share by Type (2024-2034)
Figure 18. Europe Immune-mediated Necrotizing Myopathy Treatment Revenue Market Share by Type (2024-2034)
Figure 19. Asia-Pacific Immune-mediated Necrotizing Myopathy Treatment Revenue Market Share by Type (2024-2034)
Figure 20. Latin America Immune-mediated Necrotizing Myopathy Treatment Revenue Market Share by Type (2024-2034)
Figure 21. Middle East and Africa Immune-mediated Necrotizing Myopathy Treatment Revenue Market Share by Type (2024-2034)
Figure 22. Hospital Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 23. Clinic Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 24. Others Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 25. Global Immune-mediated Necrotizing Myopathy Treatment Market Size Share by Application: 2022 & 2034
Figure 26. North America Immune-mediated Necrotizing Myopathy Treatment Revenue Market Share by Application (2024-2034)
Figure 27. Europe Immune-mediated Necrotizing Myopathy Treatment Revenue Market Share by Application (2024-2034)
Figure 28. Asia-Pacific Immune-mediated Necrotizing Myopathy Treatment Revenue Market Share by Application (2024-2034)
Figure 29. Latin America Immune-mediated Necrotizing Myopathy Treatment Revenue Market Share by Application (2024-2034)
Figure 30. Middle East and Africa Immune-mediated Necrotizing Myopathy Treatment Revenue Market Share by Application (2024-2034)
Figure 31. Immune-mediated Necrotizing Myopathy Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 32. Global Top 5 and Top 10 Players Immune-mediated Necrotizing Myopathy Treatment Market Share in 2022
Figure 33. North America Immune-mediated Necrotizing Myopathy Treatment Market Share by Country (2024-2034)
Figure 34. United States Immune-mediated Necrotizing Myopathy Treatment Market Size (2024-2034) & (US$ Million)
Figure 35. Canada Immune-mediated Necrotizing Myopathy Treatment Market Size (2024-2034) & (US$ Million)
Figure 36. Germany Immune-mediated Necrotizing Myopathy Treatment Market Size (2024-2034) & (US$ Million)
Figure 37. France Immune-mediated Necrotizing Myopathy Treatment Market Size (2024-2034) & (US$ Million)
Figure 38. U.K. Immune-mediated Necrotizing Myopathy Treatment Market Size (2024-2034) & (US$ Million)
Figure 39. Italy Immune-mediated Necrotizing Myopathy Treatment Market Size (2024-2034) & (US$ Million)
Figure 40. Russia Immune-mediated Necrotizing Myopathy Treatment Market Size (2024-2034) & (US$ Million)
Figure 41. Nordic Countries Immune-mediated Necrotizing Myopathy Treatment Market Size (2024-2034) & (US$ Million)
Figure 42. Asia-Pacific Immune-mediated Necrotizing Myopathy Treatment Market Share by Region (2024-2034)
Figure 43. China Immune-mediated Necrotizing Myopathy Treatment Market Size (2024-2034) & (US$ Million)
Figure 44. Japan Immune-mediated Necrotizing Myopathy Treatment Market Size (2024-2034) & (US$ Million)
Figure 45. South Korea Immune-mediated Necrotizing Myopathy Treatment Market Size (2024-2034) & (US$ Million)
Figure 46. Southeast Asia Immune-mediated Necrotizing Myopathy Treatment Market Size (2024-2034) & (US$ Million)
Figure 47. India Immune-mediated Necrotizing Myopathy Treatment Market Size (2024-2034) & (US$ Million)
Figure 48. Australia Immune-mediated Necrotizing Myopathy Treatment Market Size (2024-2034) & (US$ Million)
Figure 49. Latin America Immune-mediated Necrotizing Myopathy Treatment Market Share by Country (2024-2034)
Figure 50. Mexico Immune-mediated Necrotizing Myopathy Treatment Market Size (2024-2034) & (US$ Million)
Figure 51. Brazil Immune-mediated Necrotizing Myopathy Treatment Market Size (2024-2034) & (US$ Million)
Figure 52. Middle East & Africa Immune-mediated Necrotizing Myopathy Treatment Market Share by Country (2024-2034)
Figure 53. Turkey Immune-mediated Necrotizing Myopathy Treatment Market Size (2024-2034) & (US$ Million)
Figure 54. Saudi Arabia Immune-mediated Necrotizing Myopathy Treatment Market Size (2024-2034) & (US$ Million)
Figure 55. UAE Immune-mediated Necrotizing Myopathy Treatment Market Size (2024-2034) & (US$ Million)
Figure 56. Bottom-up and Top-down Approaches for This Report